Dennis Henner's Net Worth

$1.26 Million

Estimate Recalculated May 31, 2025 01:59AM EST

Who is Dennis Henner

Dennis Henner has an estimated net worth of $1.26 Million. This is based on reported shares across multiple companies, which include Radius Health, Inc., AFFYMAX INC, TETRALOGIC PHARMACEUTICALS Corp, EnteroMedics Inc, , ZOGENIX, INC., ARYx Therapeutics, Inc., COTHERIX INC, BARRIER THERAPEUTICS INC, TERCICA INC, RIGEL PHARMACEUTICALS INC, Imago BioSciences, Inc., HEALTHCARE ACQUISITION CORP, AERIE PHARMACEUTICALS INC, Ophthotech Corp., Oxford Immunotec Global PLC, Sientra, Inc., XCYTE THERAPIES INC, NEORX CORP, KALOBIOS PHARMACEUTICALS INC, Entasis Therapeutics Holdings Inc., Restoration Robotics Inc, Forty Seven, Inc., AVANIR PHARMACEUTICALS, Pharmasset Inc, Zalicus Inc., ACHILLION PHARMACEUTICALS INC, Somaxon Pharmaceuticals, Inc., and HELICOS BIOSCIENCES CORP.

SEC CIK

Dennis Henner's CIK is 0001249153

Past Insider Trading and Trends

2004 was Dennis Henner's most active year for acquiring shares with 3 total transactions. Dennis Henner's most active month to acquire stocks was the month of May. 2005 was Dennis Henner's most active year for disposing of shares, totalling 10 transactions. Dennis Henner's most active month to dispose stocks was the month of December. 2013 saw Dennis Henner paying a total of $0.00 for 15,000 shares, this is the most they've acquired in one year. In 2023 Dennis Henner cashed out on 37,999 shares for a total of $939,420.00, their largest year based on trade value.

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

EnteroMedics Inc

Investor

Updated Dec 15, 2010


Form 4	—	—	—	—	Dec 15, 2010	1.67M	Options	—	Dec 14
Form 4	—	1.41M	$0.93	$1.30M	Oct 04, 2010	1.41M	Purchase	—	Sep 30
Form 4	65.79%	2.65M	$0.64	$2.14M	Feb 25, 2009	6.67M	Purchase	—	Feb 24
Form 4	24.50%	792.03K	$8.00	—	Nov 21, 2007	4.03M	Purchase	—	Nov 20
Form 3	—	—	—	—	Nov 14, 2007	—	—	—	—

Showing 5 results

ARYx Therapeutics, Inc.

Investor

Updated Oct 04, 2010


Form 4	—	500.00K	$0.01	$6.25K	Oct 04, 2010	500.00K	Purchase	—	Sep 30
Form 4	—	500.00K	$0.01	$6.25K	Aug 17, 2010	500.00K	Purchase	—	Aug 13
Form 4	64.97%	2.32M	$1.17	$4.00M	Nov 17, 2008	5.90M	Purchase	—	Nov 14
Form 4	9.16%	300.00K	$10.00	—	Nov 13, 2007	3.58M	Purchase	—	Nov 13
Form 3	—	—	—	—	Nov 07, 2007	—	—	—	—

Showing 5 results

COTHERIX INC

Investor

Updated Jan 10, 2007


Form 4	-100.00%	-3.57M	$13.50	-$48.23M	Jan 10, 2007	—	Disposition	—	Jan 09
Form 4	-4.56%	-170.56K	$13.00	-$2.22M	Oct 19, 2005	3.57M	Sale	—	Oct 19
Form 4	-6.32%	-252.69K	$13.00	-$3.28M	Oct 13, 2005	3.74M	Sale	—	Oct 12
Form 4	—	775.53K	$6.00	$3.33M	Oct 21, 2004	4.00M	Purchase	—	Oct 20
Form 3	—	—	—	—	Oct 15, 2004	—	—	—	—

Showing 5 results

BARRIER THERAPEUTICS INC

Investor

Updated Mar 03, 2005


Form 4	-16.48%	-384.24K	$19.50	-$7.49M	Mar 03, 2005	1.95M	Sale	—	Feb 15
Form 4	-0.43%	-10.00K	$17.90	-$179.00K	Dec 22, 2004	2.33M	Sale	—	Dec 20
Form 4	9.34%	200.00K	$15.00	$3.00M	May 05, 2004	2.34M	Purchase	—	May 04
Form 4	-50.00%	-2.14M	—	—	Apr 29, 2004	2.14M	Options	—	Apr 28
Form 3	—	—	—	—	Apr 28, 2004	—	—	—	—

Showing 5 results

PHARMATHENE, INC

Investor

Updated Nov 05, 2010

View Quote Details


Form 4	7.27%	430.00K	$2.69	$7.68M	Nov 05, 2010	6.35M	Purchase	—	Nov 03
Form 4	—	2.41M	—	—	Jul 30, 2009	729.11K	Acq/Dis	—	Jul 28
Form 4/A	3,069.20%	3.84M	$7.70	—	Oct 03, 2007	3.49M	Purchase	—	Aug 03 - Aug 07
Form 4	3,050.84%	3.81M	$7.70	—	Aug 07, 2007	3.47M	Purchase	—	Aug 03 - Aug 07
Form 3	—	—	—	—	Aug 07, 2007	125.00K	—	—	—

Showing 5 results

PONIARD PHARMACEUTICALS, INC.

Investor

Updated Nov 09, 2009


Form 4	-7.22%	-494.96K	$8.19	-$4.05M	Nov 09, 2009	6.36M	Sale	—	Nov 05 - Nov 09
Form 4	15.11%	900.00K	$6.33	$5.70M	May 01, 2007	6.86M	Purchase	—	Apr 30
Form 3	—	—	—	—	Apr 27, 2006	35.75M	—	—	—

Showing 3 results

Zalicus Inc.

Investor

Updated Oct 28, 2011


Form 4	-6.22%	-738.81K	$1.03	-$760.97K	Oct 28, 2011	11.13M	Sale	—	Oct 27
Form 4	-2.31%	-281.20K	$1.02	-$286.82K	Oct 27, 2011	11.87M	Sale	—	Oct 25 - Oct 26
Form 4	-2.58%	-322.10K	$1.03	-$331.06K	Oct 25, 2011	12.15M	Sale	—	Oct 21 - Oct 24
Form 4	-3.55%	-459.82K	$1.03	-$473.26K	Oct 21, 2011	12.48M	Sale	—	Oct 19 - Oct 20
Form 4	-0.15%	-19.64K	$1.02	-$20.04K	Oct 19, 2011	12.94M	Sale	—	Oct 17
Form 4	-0.34%	-44.70K	$1.02	-$45.59K	Oct 17, 2011	12.96M	Sale	—	Oct 13 - Oct 14
Form 4	-2.54%	-338.30K	$40.36	-$13.65M	Oct 13, 2011	13.00M	Sale	—	Oct 11 - Oct 12
Form 4	-3.65%	-505.20K	$1.03	-$522.66K	Oct 11, 2011	13.34M	Sale	—	Oct 07 - Oct 10
Form 4	-2.67%	-380.23K	$1.02	-$387.84K	Oct 06, 2011	13.84M	Sale	—	Sep 28 - Oct 06
Form 4	-2.80%	-410.00K	$1.10	-$451.10K	Sep 28, 2011	14.22M	Sale	—	Sep 26 - Sep 27
Form 4	-35.10%	-7.91M	—	—	Jan 04, 2010	14.63M	Disposition	—	Jan 01
Form 3	—	—	—	—	Dec 22, 2009	22.55M	—	—	—

Showing 12 results

Somaxon Pharmaceuticals, Inc.

Investor

Updated Jul 10, 2012


Form 4	-64.28%	-2.30M	$0.30	-$694.07K	Jul 10, 2012	1.28M	Sale	—	Jul 06 - Jul 09
Form 4	-4.76%	-178.56K	$0.29	-$51.78K	Jul 05, 2012	3.57M	Sale	—	Jul 02 - Jul 03
Form 4	-0.52%	-19.50K	$0.29	-$5.65K	Jul 02, 2012	3.75M	Sale	—	Jun 28
Form 4	-0.32%	-12.00K	$0.29	-$3.48K	Jun 21, 2012	3.76M	Sale	—	Jun 19
Form 4	-0.04%	-1.45K	$0.29	-$420.50	Jun 19, 2012	3.78M	Sale	—	Jun 15
Form 4	-0.99%	-37.95K	$0.29	-$11.01K	Jun 07, 2012	3.78M	Sale	—	Jun 05 - Jun 06
Form 4	-17.52%	-811.42K	$0.30	-$244.40K	Jun 04, 2012	3.82M	Sale	—	May 22 - May 31
Form 4	76.08%	2.55M	$0.59	$1.50M	Jul 09, 2009	5.91M	Purchase	—	Jul 08
Form 4	-2.13%	-72.90K	$18.23	-$1.33M	May 10, 2007	3.36M	Sale	Scheduled	May 08
Form 4	-0.11%	-3.80K	$18.00	-$68.40K	May 08, 2007	3.43M	Sale	Scheduled	May 04
Form 4	-0.94%	-32.60K	$18.07	-$589.14K	May 03, 2007	3.43M	Sale	Scheduled	May 01 - May 02
Form 4	-1.77%	-62.60K	$18.07	-$1.13M	May 01, 2007	3.47M	Sale	Scheduled	Apr 27 - Apr 30
Form 4	-81.68%	-15.73M	$11.00	—	Dec 22, 2005	3.53M	Buy-Options	—	Dec 20
Form 3	—	—	—	—	Dec 14, 2005	—	—	—	—

Showing 14 results

HELICOS BIOSCIENCES CORP

Investor

Updated May 31, 2007


Form 4	-74.99%	-8.96M	$9.00	$3.00M	May 31, 2007	2.99M	Buy-Options	—	May 30
Form 3	—	—	—	—	May 24, 2007	—	—	—	—

Showing 2 results

TETRALOGIC PHARMACEUTICALS Corp

Investor

Updated Feb 10, 2016


Form 4	-13.09%	-333.63K	$0.17	-$56.47K	Feb 10, 2016	2.21M	Sale	—	Feb 08 - Feb 09
Form 4	-35.71%	-1.42M	$0.18	-$248.97K	Feb 05, 2016	2.55M	Sale	—	Feb 03 - Feb 05
Form 4	-8.52%	-369.13K	$0.19	-$71.71K	Feb 02, 2016	3.96M	Sale	—	Jan 29 - Feb 02
Form 4	-6.72%	-311.93K	$0.28	-$85.98K	Jan 28, 2016	4.33M	Sale	—	Jan 26 - Jan 28
Form 4	44.26%	1.43M	$6.70	-$149.06K	Dec 19, 2013	4.64M	Purchase	—	Dec 17
Form 3	—	—	—	—	Dec 11, 2013	—	—	—	—

Showing 6 results

Investor

Updated Sep 04, 2013


Form 4	-100.00%	-7.24M	—	—	Sep 04, 2013	—	Disposition	—	Sep 03
Form 4	-9.99%	-804.23K	$11.16	-$8.98M	Aug 10, 2012	7.24M	Sale	—	Aug 08
Form 3	—	—	—	—	Aug 02, 2012	604.27K	—	—	—

Showing 3 results

ZOGENIX, INC.

Investor

Updated Sep 20, 2011


Form 4	58.50%	3.50M	$2.00	$7.00M	Sep 20, 2011	9.48M	Purchase	—	Sep 16
Form 4	-82.59%	-28.38M	$4.00	—	Nov 30, 2010	5.98M	Buy-Options	—	Nov 29
Form 3	—	—	—	—	Nov 22, 2010	—	—	—	—

Showing 3 results

Radius Health, Inc.

Investor

Updated Sep 29, 2016


Form 4	-33.33%	-1.23M	—	—	Sep 29, 2016	2.46M	Disposition	—	Sep 27
Form 4	483.72%	3.06M	—	—	Jun 10, 2014	3.69M	Options	—	Jun 06
Form 4	—	319.11K	$33.78	$7.00M	Apr 30, 2013	319.11K	Purchase	—	Apr 23
Form 4	29.48%	61.41K	—	—	Dec 16, 2011	269.72K	Purchase	—	Dec 14
Form 4	41.80%	61.41K	—	—	Nov 22, 2011	208.32K	Purchase	—	Nov 18
Form 3	—	—	—	—	May 19, 2011	—	—	—	—

Showing 6 results

AERIE PHARMACEUTICALS INC

Investor

Updated Jan 30, 2015


Form 4	-100.00%	-3.14M	—	—	Jan 30, 2015	—	Disposition	—	Jan 28
Form 4/A	10.20%	321.00K	$10.00	$3.21M	Jan 30, 2015	3.47M	Purchase	—	Oct 25
Form 4	-5.00%	-175.00K	$31.11	-$5.44M	Jan 12, 2015	3.32M	Sale	—	Jan 08
Form 4	-0.67%	-23.62K	$30.86	-$728.91K	Jan 06, 2015	3.50M	Sale	—	Jan 05
Form 4	-2.24%	-80.72K	$30.05	-$2.43M	Dec 30, 2014	3.52M	Sale	—	Dec 26 - Dec 29
Form 4	-1.36%	-49.70K	$30.36	-$1.51M	Dec 24, 2014	3.60M	Sale	—	Dec 22 - Dec 23
Form 4	—	13.50K	—	—	Jun 16, 2014	13.50K	Grant	—	Jun 11
Form 4	9.63%	321.00K	$6.36	—	Oct 28, 2013	3.65M	Purchase	—	Oct 25
Form 3	—	—	—	—	Oct 25, 2013	—	—	—	—

Showing 9 results

Ophthotech Corp.

Investor

Updated May 28, 2015


Form 4	-100.00%	-1.55M	—	—	May 28, 2015	—	Disposition	—	May 26
Form 4	-6.92%	-211.68K	$44.87	-$9.61M	Jun 11, 2014	2.85M	Sale	—	Jun 09 - Jun 11
Form 4	—	—	—	—	Oct 02, 2013	5.27M	Options	—	Sep 30
Form 3	—	—	—	—	Sep 25, 2013	—	—	—	—

Showing 4 results

AVANIR PHARMACEUTICALS, INC.

Investor

Updated Dec 07, 2010


Form 4	-100.00%	-6.67M	—	—	Dec 07, 2010	12.00	Disposition	—	Dec 03
Form 4	-15.73%	-1.24M	$4.82	-$6.00M	Nov 10, 2010	6.67M	Sale	—	Nov 08 - Nov 09
Form 4	-17.96%	-1.73M	$4.58	-$7.93M	Nov 05, 2010	7.91M	Sale	—	Nov 03 - Nov 05
Form 4	-35.00%	-5.19M	$5.06	-$26.29M	Nov 02, 2010	9.65M	Sale	—	Oct 29 - Nov 02
Form 4	-3.59%	-551.84K	$3.50	-$1.93M	Oct 12, 2010	14.84M	Sale	—	Oct 08 - Oct 11
Form 4	-1.06%	-165.00K	$3.53	-$583.14K	Jul 15, 2010	15.39M	Sale	—	Jul 13
Form 3	—	—	—	—	Apr 11, 2008	15.56M	—	—	—

Showing 7 results

ACHILLION PHARMACEUTICALS INC

Investor

Updated Jun 06, 2012


Form 4	-100.00%	-10.94M	—	—	Jun 06, 2012	3.00	Disposition	—	Jun 04
Form 4	-10.74%	-1.32M	$5.39	-$9.11	Jun 04, 2012	10.94M	Sale	—	May 31
Form 4	150.05%	6.58M	$2.49	$12.14M	Aug 20, 2010	10.97M	Purchase	—	Aug 20
Form 4	-5.06%	-233.99K	$3.77	-$881.37K	Jan 13, 2010	4.39M	Sale	Scheduled	Jan 11
Form 4	-1.13%	-53.00K	$3.50	-$185.63K	Jan 08, 2010	4.62M	Sale	Scheduled	Jan 06 - Jan 07
Form 4	-0.08%	-3.60K	$3.53	-$12.70K	Dec 29, 2009	4.67M	Sale	Scheduled	Dec 24
Form 4	-5.72%	-284.00K	$3.69	-$1.05M	Dec 23, 2009	4.68M	Sale	Scheduled	Dec 21 - Dec 23
Form 4	-4.01%	-207.18K	$3.53	-$730.32K	Dec 18, 2009	4.96M	Sale	Scheduled	Dec 16 - Dec 18
Form 4	0.09%	4.65K	$2.25	$10.48K	Sep 09, 2008	5.31M	Purchase	—	Sep 05 - Sep 08
Form 3	—	—	—	—	Aug 20, 2008	5.16M	—	—	—

Showing 10 results

TERCICA INC

Investor

Updated May 24, 2007


Form 4	—	11.25K	—	—	May 24, 2007	11.25K	Grant	—	May 24
Form 4	—	11.25K	—	—	Jun 20, 2006	11.25K	Grant	—	Jun 06
Form 4	-0.12%	-8.40K	$12.00	-$100.80K	Sep 12, 2005	6.86M	Sale	—	Sep 07
Form 4	-2.76%	-194.83K	$12.25	-$2.39M	Sep 07, 2005	6.87M	Sale	—	Sep 02 - Sep 06
Form 4	—	11.25K	—	—	Jun 02, 2005	11.25K	Grant	—	Jun 01
Form 4	10.48%	670.00K	$9.00	$6.03M	Mar 23, 2004	7.06M	Purchase	—	Mar 22
Form 3/A	—	—	—	—	Mar 16, 2004	5.00K	—	—	—
Form 3	—	—	—	—	Nov 24, 2003	—	—	—	—

Showing 8 results

RIGEL PHARMACEUTICALS INC

Investor

Updated Jan 10, 2005

View Quote Details


Form 4	-100.00%	-17.25K	$23.27	-$401.38K	Jan 10, 2005	—	Sale	—	Jan 05
Form 4	-100.00%	-868.05K	$23.49	-$20.39M	Nov 29, 2004	17.25K	Sale	—	Nov 23
Form 4	—	—	$5.76	$5.00M	Oct 06, 2004	885.31K	Options	—	Oct 04
Form 4	-98.98%	-1.67M	—	—	Sep 15, 2004	17.25K	Disposition	—	Sep 13
Form 4	-4.80%	-85.03K	$20.75	-$1.76M	Sep 02, 2004	1.69M	Sale	—	Aug 31 - Sep 01
Form 4	-1.80%	-32.50K	$21.83	-$709.47K	Aug 23, 2004	1.77M	Sale	—	Aug 19 - Aug 20
Form 4	-1.04%	-19.00K	$22.26	-$422.94K	Aug 18, 2004	1.81M	Sale	—	Aug 17 - Aug 18
Form 4	-0.55%	-10.00K	$22.30	-$223.00K	Aug 17, 2004	1.83M	Sale	—	Aug 13
Form 4	-45.00%	-1.50M	$15.83	-$45.54K	Jun 30, 2004	1.84M	Sale	—	Jun 28
Form 4	-3.59%	-124.31K	$15.66	-$1.95M	Jun 28, 2004	3.34M	Sale	—	Jun 24 - Jun 25
Form 4	-0.86%	-30.19K	$15.51	-$468.17K	Jun 24, 2004	3.46M	Sale	—	Jun 22 - Jun 23
Form 4	—	10.00K	—	—	Jun 14, 2004	10.00K	Grant	—	Jun 10 - Jun 11
Form 4	-0.06%	-2.03K	$18.00	-$36.54K	Jun 03, 2004	3.49M	Sale	—	Jun 02
Form 4	-0.40%	-13.95K	$17.96	-$250.60K	Jun 02, 2004	3.49M	Sale	—	May 28 - Jun 01
Form 4	-0.74%	-26.02K	$17.84	-$464.00K	May 27, 2004	3.51M	Sale	—	May 26 - May 27
Form 4	-0.09%	-3.30K	$17.35	-$57.25K	May 26, 2004	3.53M	Sale	—	May 24
Form 4	-3.79%	-139.31K	$17.25	-$2.40M	May 21, 2004	3.54M	Sale	—	May 20
Form 4	-4.14%	-158.70K	$20.71	-$3.29M	Apr 21, 2004	3.68M	Sale	—	Apr 19 - Apr 21
Form 4	-7.62%	-316.30K	$19.93	-$6.30M	Apr 13, 2004	3.83M	Sale	—	Apr 08 - Apr 12
Form 4	-0.42%	-17.33K	$20.00	-$346.68K	Mar 23, 2004	4.15M	Sale	—	Mar 19
Form 4	-3.97%	-172.37K	$20.00	-$3.45M	Feb 23, 2004	4.17M	Sale	—	Feb 19
Form 3	—	—	—	—	Jul 07, 2003	—	—	—	—

Showing 22 results

Imago BioSciences, Inc.

Investor

Updated Jan 11, 2023


Form 4	-100.00%	-38.00K	$36.00	-$939.42K	Jan 11, 2023	—	Disposition	—	Jan 11
Form 4	—	11.90K	—	—	Jun 03, 2022	26.10K	Grant	—	Jun 01
Form 3	—	—	—	—	Jul 15, 2021	—	—	—	—

Showing 3 results

Oxford Immunotec Global PLC

Investor

Updated Jun 17, 2015


Form 4	-1.81%	-41.23K	$14.30	-$589.54K	Jun 17, 2015	2.24M	Sale	—	Jun 15 - Jun 16
Form 4	-1.37%	-31.60K	$14.27	-$450.77K	Jun 12, 2015	2.28M	Sale	—	Jun 11 - Jun 12
Form 4	-1.06%	-24.65K	$14.28	-$352.01K	Jun 10, 2015	2.31M	Sale	—	Jun 08 - Jun 10
Form 4	-1.54%	-36.47K	$14.29	-$521.09K	Jun 03, 2015	2.33M	Sale	—	Jun 01 - Jun 03
Form 4	-2.20%	-53.41K	$14.49	-$773.75K	Mar 24, 2015	2.37M	Sale	—	Mar 20 - Mar 23
Form 4	-5.98%	-154.32K	$14.65	-$2.26M	Mar 19, 2015	2.42M	Sale	—	Mar 17 - Mar 19
Form 4	—	—	—	—	Nov 25, 2013	2.58M	Options	—	Nov 22
Form 3	—	—	—	—	Nov 21, 2013	—	—	—	—

Showing 8 results

Sientra, Inc.

Investor

Updated Feb 09, 2016

View Quote Details


Form 3	—	—	—	—	Feb 09, 2016	2.73M	—	—	—

Showing 1 results

XCYTE THERAPIES INC

Investor

Updated Mar 10, 2004

View Quote Details


Form 3	—	—	—	—	Mar 10, 2004	—	—	—	—

Showing 1 results

KALOBIOS PHARMACEUTICALS INC

Investor

Updated May 03, 2013

View Quote Details


Form 4	—	15.00K	—	—	May 03, 2013	15.00K	Grant	—	May 01
Form 4	2.73%	69.89K	—	—	Feb 07, 2013	2.63M	Options	—	Feb 05
Form 3	—	—	—	—	Aug 10, 2012	—	—	—	—

Showing 3 results

Entasis Therapeutics Holdings Inc.

Investor

Updated Oct 02, 2018


Form 4	-90.18%	-21.20M	$15.00	—	Oct 02, 2018	2.31M	Buy-Options	—	Sep 28
Form 3	—	—	—	—	Sep 25, 2018	—	—	—	—

Showing 2 results

Restoration Robotics Inc

Investor

Updated Oct 17, 2017

View Quote Details


Form 4	—	—	$7.00	—	Oct 17, 2017	3.57M	Options	—	Oct 16
Form 4	—	—	—	—	Oct 13, 2017	—	Acq/Dis	—	Oct 11
Form 3	—	—	—	—	Oct 11, 2017	—	—	—	—

Showing 3 results

Forty Seven, Inc.

Investor

Updated Apr 07, 2020


Form 4	-100.00%	-30.97K	—	—	Apr 07, 2020	—	Disposition	—	Apr 07
Form 4	—	10.32K	—	—	Jun 14, 2019	10.32K	Grant	—	Jun 12
Form 4	4.39%	200.00K	$16.00	—	Jul 02, 2018	4.76M	Purchase	—	Jul 02
Form 4	5.53%	200.00K	$16.00	—	Jul 02, 2018	3.82M	Purchase	—	Jul 02
Form 3	—	—	—	—	Jun 27, 2018	—	—	—	—
Form 3	—	—	—	—	Jun 27, 2018	—	—	—	—

Showing 6 results

Pharmasset Inc

Investor

Updated Apr 26, 2007


Form 3	—	—	—	—	Apr 26, 2007	830.82K	—	—	—

Showing 1 results

AFFYMAX INC

Investor

Updated Dec 21, 2006


Form 4	6.20%	93.41K	$21.00	-$53.00	Dec 21, 2006	1.60M	Options	—	Dec 19 - Dec 20
Form 3	—	—	—	—	Dec 14, 2006	31.25K	—	—	—

Showing 2 results